Trademark: 88125511
Word
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,800 MG PER 180 ML (10 MG/ML)
Status Date
Tuesday, December 22, 2020
Registration Number
6228560
Registration Date
Tuesday, December 22, 2020
Filing Date
Thursday, September 20, 2018
Published for Opposition
Tuesday, February 26, 2019
5 medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
10 medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine
The color(s) green, white and black is/are claimed as a feature of the mark.
"GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,800 MG PER 180 ML (10 MG/ML)"
The mark consists of a green outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" in black lettering, along with a green arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in green, with the words "1,800 mg per 180 mL (10 mg/mL)" in white letters. The color white in the rectangle with the arched curve represents background only and is not claimed as a feature of the mark.
Dec 22, 2020
Registered-Principal Register
Nov 17, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 16, 2020
Allowed Principal Register - Sou Accepted
Oct 28, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2020
Extension 3 Granted
Oct 23, 2020
Extension 3 Filed
Oct 23, 2020
Teas Extension Received
Oct 13, 2020
Statement Of Use Processing Complete
Sep 29, 2020
Use Amendment Filed
Oct 13, 2020
Case Assigned To Intent To Use Paralegal
Sep 29, 2020
Teas Statement Of Use Received
Apr 24, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 22, 2020
Extension 2 Granted
Apr 22, 2020
Extension 2 Filed
Apr 22, 2020
Teas Extension Received
Oct 25, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 23, 2019
Extension 1 Granted
Oct 23, 2019
Extension 1 Filed
Oct 23, 2019
Teas Extension Received
Apr 23, 2019
Noa E-Mailed - Sou Required From Applicant
Feb 26, 2019
Official Gazette Publication Confirmation E-Mailed
Feb 26, 2019
Published For Opposition
Feb 6, 2019
Notification Of Notice Of Publication E-Mailed
Jan 18, 2019
Approved For Pub - Principal Register
Jan 15, 2019
Examiner's Amendment Entered
Jan 15, 2019
Notification Of Examiners Amendment E-Mailed
Jan 15, 2019
Examiners Amendment E-Mailed
Jan 15, 2019
Examiners Amendment -Written
Jan 14, 2019
Previous Allowance Count Withdrawn
Jan 8, 2019
Withdrawn From Pub - Og Review Query
Dec 21, 2018
Assigned To Lie
Nov 29, 2018
Approved For Pub - Principal Register
Nov 29, 2018
Examiner's Amendment Entered
Nov 29, 2018
Notification Of Examiners Amendment E-Mailed
Nov 29, 2018
Examiners Amendment E-Mailed
Nov 29, 2018
Examiners Amendment -Written
Nov 28, 2018
Assigned To Examiner
Sep 27, 2018
Notice Of Design Search Code E-Mailed
Sep 26, 2018
New Application Office Supplied Data Entered In Tram
Sep 24, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
